Search

Your search keyword '"Andes, David R."' showing total 555 results

Search Constraints

Start Over You searched for: Author "Andes, David R." Remove constraint Author: "Andes, David R." Search Limiters Full Text Remove constraint Search Limiters: Full Text
555 results on '"Andes, David R."'

Search Results

1. Addendum: A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase

2. The Candida albicans reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates filamentation, biofilm formation, and oral commensalism

3. Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal

4. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology

5. The protein kinase Ire1 impacts pathogenicity of Candida albicans by regulating homeostatic adaptation to endoplasmic reticulum stress

6. Evolution of the complex transcription network controlling biofilm formation in Candida species.

7. Risk of COVID-19 after natural infection or vaccination

8. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris.

9. Biomineral armor in leaf-cutter ants.

10. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium

11. Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients

12. Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity

13. How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers

14. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

16. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation

17. Biofilm-associated metabolism via ERG251 in Candida albicans

18. Distinct roles of the 7‐transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans

19. A Mycoses Study Group international prospective study of phaeohyphomycosis: an analysis of 99 proven/probable cases

21. Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies

22. Global Identification of Biofilm-Specific Proteolysis in Candida albicans

23. Liposomal formulation of a new antifungal hybrid compound provides protection against Candida auris in the ex vivo skin colonization model

24. An expanded regulatory network temporally controls Candida albicans biofilm formation

25. A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase

28. A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans

29. Failure of Clindamycin To Eradicate Infection with Beta-Hemolytic Streptococci Inducibly Resistant to Clindamycin in an Animal Model and in Human Infections

30. Metabolic reprogramming during Candida albicans planktonic-biofilm transition is modulated by the transcription factors Zcf15 and Zcf26.

31. Liposomal formulation of a new antifungal hybrid compound provides protection against Candida auris in the ex vivo skin colonization model

32. Risk of COVID-19 after natural infection or vaccination

33. Biofilm matrix regulation by Candida albicans Zap1.

34. Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo

36. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking

37. The antimicrobial potential of Streptomyces from insect microbiomes

41. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual

43. Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains

44. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis

45. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.

48. Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

49. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

50. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

Catalog

Books, media, physical & digital resources